UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
(Exact name of registrant as specified in its charter)
(State or other jurisdiction | (Commission File Number) | (IRS Employer Identification No.) | ||
of incorporation) | ||||
|
||||
(Address of principal executive offices) | (Zip Code) | |||
Registrant’s telephone number, including
area code:
_____________________________________________
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
Title of each class | Trading Symbol | Name of each exchange on which registered |
The |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 1.01 | Entry into a Definitive Material Agreement. |
On October 27, 2021, Aethlon Medical, Inc. (the “Company”) entered into a Lease (the “Lease”) with San Diego Inspire 5, LLC, a Delaware limited liability company (the “Landlord”), for the lease of approximately 24,915 square feet of space, consisting of (i) approximately 22,260 square feet of space located at 11588 Sorrento Valley Road, San Diego, California 92121 (the “Building”) and (ii) 2,655 square feet of space located in the Building and commonly known as Suite 18 (the “Suite Premises” and together with the Building, the “Premises”). The Lease is expected to commence on the date upon which the Premises are ready for occupancy or on such date as the Company commences to conduct business on the Premises, and has an initial term of 58 months after the commencement date of the Lease (the “Initial Term”). The Lease provides the Company with an option to extend the Initial Term for one additional renewal term of five years (the “Option Term”). During the first year of the Initial Term, the Company is required to pay base rent of $12,080.25 per month for the Premises. Thereafter, the base rent will increase each year for the Premises and in the fifth year of the Initial Term, the Company is required to pay base rent of $13,593.60 per month for the Premises. If the Company elects to extend the Lease beyond the Initial Term, then the base rent for the Option Term will be the fair rental value (as calculated in the Lease) for the Premises as of the commencement date of the Option Term. The Company will also be responsible for the payment of the Company’s share of certain operating expenses and tax expenses of the buildings, subject to certain exceptions. In the event of a default of certain of the Company’s obligations under the Lease, the Landlord may terminate the Lease and recover damages as provided by the Lease and by law.
The foregoing description of the Lease is only a summary and is qualified in its entirety by the terms of the Lease, a copy of which the Company expects to file as exhibits to the Company’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2021.
2 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Aethlon Medical, Inc. | ||||||
Dated: November 1, 2021 | By: | /s/ James B. Frakes | ||||
James B. Frakes Chief Financial Officer |
3 |
Cover |
Oct. 27, 2021 |
---|---|
Cover [Abstract] | |
Document Type | 8-K |
Amendment Flag | false |
Document Period End Date | Oct. 27, 2021 |
Entity File Number | 001-37487 |
Entity Registrant Name | Aethlon Medical, Inc. |
Entity Central Index Key | 0000882291 |
Entity Tax Identification Number | 13-3632859 |
Entity Incorporation, State or Country Code | NV |
Entity Address, Address Line One | 11555 Sorrento Valley Road |
Entity Address, Address Line Two | Suite 203 |
Entity Address, City or Town | San Diego |
Entity Address, State or Province | CA |
Entity Address, Postal Zip Code | 92121 |
City Area Code | 858 |
Local Phone Number | 459-7800 |
Written Communications | false |
Soliciting Material | false |
Pre-commencement Tender Offer | false |
Pre-commencement Issuer Tender Offer | false |
Title of 12(b) Security | Common Stock |
Trading Symbol | AEMD |
Security Exchange Name | NASDAQ |
Entity Emerging Growth Company | false |
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end
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
][C^?;L?QG*:DS83# M%M-66 MM6"35SVZ]2 MFK"8VKC/I#J3ME=;?O/! EEB] TL6WT>[V3_AO7PJ][1F:]L+U3,]>Y M6E%WK_6%HIH*DPN^M0?VBM"5L9V*)F5%KOV7^6>8<44V':<7M5TORU+;HOU8 M6&[<*1WB,M[S@;MHR /!9<_.F6L:=V;RN9M0UG40W(><1D["_O,];^AJHHTB ML2EKXF1">5[_=VMS8-)MP*N2Q*.ML=JI?8M#GW9#=Z7B2*J$*LNZK(NH>"]@ MQYUT8]%=$&4K:L=SQK>QGBJ9^NAL2$B/H[N@;!/-T+RR[2?.AR$GLVJOV'RKM*&A/GOC"A#%5]#2!\9 M V'_C@G;HQ")]Z,B0C/'!P+\V!I(_ _4&P^/1B3DXSGEW&5S1(!Z>94]$/L; M3.Q^G:\ _,VSN[[;2PN<_4X1(/X_7PO^([5($;BGBLG$7M(5@/V1,9#Z&29U MCT)4WCFH+S'WS8!_*04 ^9C@DO/!K:8SJ,N\( 2BH[Q5+B5J/65P_:!S;0F&C9)9A@2BT'\EJE%A5;,J*B<%Z MZ-XB4/8H:25(+DH(1B*6:B%W'A9&;/Q_5 )L$AO:8@-!PH^>8+I*,$Y2I) M+"Z]^7/+!.V%0E%I#IXCP@M 0.8KP=Y_&?8^'#M*'EHK\Y5@/WT9]E,X=I1< MM%8F)O:!_7BG'N72,P/M-88B1\E%:R1B L^O-'?J7LEG5JR/JJ-^5 **'C%% M#8M%[?#%11[2VTM+*&_$=+5:'";G>ZD-X?^Q1=V=9+4]E#EBXAH2VO0#QB+N M[J&%;RG1@0F4+TJN6BFG::0NPHH2?_?=MX "14E J\0TS/-6NKF/N13!Y['' M5E"N*)FD3U33 Z];3JR]I_[.U^ 5;"C#ZJ&,AC%^4\Q8#P8R33.Q>4;CF17S MF$+QHJ1_07D-HQY+SF)FF)A]LG>(BA%>S;G*#@H9)=GS"VN8\+VB+M+4WG;G MZ[C@-U-YWZ1MZ0/90X2JY7+Q27_$CKC*J7\J\H!8T"2MH'%=WT.$/CS Y[ MZUY_\NAVS'A&F2,K*&N4E,\GJF&VG^6C(F[;WGB=3B3W;P^I-(021DGP M(: MAKSG1S7> Q,H6)3,KE(.TIAPLXKG1,RH?_5"M244,$JF%Q*'-O;.0&/O[(5C M+TK&YQ.%Q+98&V[/J+L)9S/BWTD6+ #>9X-)/""UZ?U[^98?MZ-;I;D?0_NA M&KO'% H<9XMD2%[3J+.$&9H4+@V9("*V*=5V7YLG.Z\O!0T SAY*H&B4Q_O? M*.(M H(,XAULA%"<%7R3-+2>4+097G'/"80I$C MSAUZY.&LO2P6-6^O/<6K.T+$?26@X!$G$<-BD=:G&>I\9L_T/3%DXV&(OZ\$ ME#_BA&)8+-KZ>36P%YZ9#,^9'QA":2,NA:V4A@)YG!+.KS/-!-7!L>7 $ H9 M< E#HB"M;@U)QX*]^[",O]K\%R5=8 M@]].@(C=*Q+KM1MQ[!92%%=RD1#EH1ZRAW)'W5CI%]HP^3LSIVKW_BEW9F3S MMM"BA_I2T"B@I*M0T3C7UIV=_,%+ZYX=E#=B8EHE#&?/5#;A+!YR28+WY7MF M4+Z(66B%+!2\UT0\J6QAXO6]DC&E;OI$;\\V0$($K :$L3\]$4H6]'Z+C/YBTRM?\&'!L%RT-!@;N($"$>Z"](_-GK1Y'K]0*=4N64* MCW1EKFU#3^&;(D!Q:'Q0WR@$QE 1IHOND:Y;>\"]J[;XQOUR[V.U1_X'4$L# M!!0 ( .N)85.R PXEA!, (QG . 865T:&QO;E\X:RYH=&WM/6U3 MXLK2WZWR/\SE/N>6UN4M 134Y18"*KX+[*Z[7ZPA&2 2DI!)$,ZO?[HG"200 M%%WT>$ZMYP7)S'3W]/3[S,2C_TV&.ADSFVNF\24AI;,)P@S%5#6C]R7A.MU4 M,?&_\O;64=^!?M#7X%\2?<>Q#C*9IZ>G]%,N;=J]C%0JE3(3[)/P.AU,8OO) MV:R4N;^Z;"E]-J0IS> .-10V&Z1KQF U?&R==>W8NA;IBD\")+G,$FAH5><# MPIWW,EYCI*L3V[7@=76"KAHW\[*T_QP=7H_9@,FJOA+2##-D]\?-RWEW)[[_ MO&O&L:G!NZ8]I ZL(4(JI+)R2MX+ 4EQID0 P?=TSQR_"*>8RDD!G*7%B !UJ"CRU,]2JU9YR[E'='1;Q!04UDI M1#.TV*;.>.P8T1(S2#%=P[&G\=3[C9$9<-M91@ /8V!7ZE>U65_*G+YN&D.F M:@K5TXHY%".DK+R?$$K'J J?!'^.',W16?DHXWU"ZY YE""D%!NYVOA+HFH: M#C.<5'MJP2HHWK ?C:^D.NG58JM_"!Y)%4:MW1N?P#3OAA>:(/P41? 2V?G8UZ MR_#"R0,#V8-9P+]U _@XK0*#;*HW#)5-+MCT(0L_Q:(LEUXSR4(I!+ D"X>/8: M.#6DY=:'E5LB:27PCJE."7>F.ON2Z((0'A I:SFDK0VARS5[(DUS2(VD]R ) M!-A:5XB[JHV#<:K&+9U.#XAA&DPT:I,#E%MFHT*(;YJJ,D.H!WZ%CM?N$& I MGN1/G";:E1/;' HME+(I>=\QY[\GB &S!E1,.XB5AD1Y+@Y'F0B*7\'JF=@O M"3#+!QT33! UA)B$Z8E(4:(LVF-)R$08@12!O60VN'#&O1YHE@^X\+= &A%. M]* O;"YE0S45*%)ZPM6$W^R ?F2X-K0TIEG-'Q44> >.FZZ=H -N@FI./"9 M033U668$QBT8QL0ZS)[.GFLJMG0U9A,Q%1;KS*J-B^B:+0Z>H\O$XO.Q6.BS-,IGU] \)H-"+G%S MR"AW;5;V-?< ^@3 @J8H"H2V KYG!E:B\)D@.KT9Q]S<+.$!TP#+N,Q;'"L4 M@CJF'6I^/0\6:8R#&D):8X8YU(R7T+[,ET6\<8"#]@@7EACJ:VA('SWS$%C- MHPR,AT_\Y\AZK84^)$-J]S3C@["%!84Q17>O!(P44B=F)\E&G_/6ZT:[7 M2*M=:==;1YD.1"Q6^7U1MNK5K\U&NU%OD 5Z],ZJ=Y<735:K<;- M]0\9WR/N1-C@GC:^EJFLC90K[T,;C_\V]I+WOX,;A.;II7Y(A;U!!JB]%" M*5L405 J53,5%ST7!J$/RBQ>FT=N?PX'][+3ZQJ-5@G _:KK#N-+E(NIBT4_ M>91!2LL?P)I@#=Z;_R#MS?IUFS3KMS?-]L>L^:UK (7[G+<-&XJ[2D_+F[ P,;A390K7D9/KKR4/DD:AI+^ MZQ9GISZA8 &0:M0->T8MH9QPBRD8_ZM$ \8ZG(#- %6Q=S]68AS:T1DTZCIP M11$%UFQ"?+>HJ@;?7TW(DZ8Z?>R:_>.0=$P;@KV48NHZM3CD],%O7D1]Y-@! M@C&S'5RY@.B.Z3CF, B\CQPUZ.C#S\D 'JE*<>U/YI&V0H:% (?F$1H1*^&% MB(2#()DVV#)1AFPY8 6J7LFM:JHK!#[?.&-FJW,V*FJ;L%18+<6$SF&6;8Y1 MIJ*F:@TZ$^5K-J8J?58C_%\==273I3_F4O1,MUS^W=;F.+(V)YK.8"I@D.,7 M@IG-^]-^X6[_&]V8Y9GCQ.1>2N7V\\7]#^+K^\F\%.%KFTX:?I5"$?+T'),G M(WU0O1Q/^,7;I7V1R2L(2)2E7"JWEY.+A=*:+(?_V6^V-1O@]8Y010Q,38@5 M;?((H2(''X63BA6-9P5A$P15S>%0X[C!1E"6BI#2S>GP)OH MDI-K,[W[F982'+D6-K*O8-G;'KYMPN!BD:POB=P*HS+K(" YAQ?#/)$N>5J8-WD;.[%6/MC M1:,4Q[ ;Z3\U:'?DW>Y4[1N_.K;&T:0F*8$^42[+T0O7A5QUGR+)OTN/[T\&TV+)! M+C2+ZH1-F.(ZVABS9?#_C/]%X0BPER!_-Q!WO.2&7^'],R)5+[]GE6=>3_G/ MOXNRM'_(H:?.K+YI,&*("#&)T8_N8F5@>XO:C,(456#=HN[D?-U!DU>!;JNU M)7O\TYRT3JXN]$TXXC"^1+E8**[0CM0BP76?X$L3%O069_Q ITM/!Y\I9ZI M L'O$J^N#\8&7=GVEDYY4.-.?W#=[E>1@!_N,V4@MBZH!7X 'U-=@@\S\E%759>\8[[!F M@'/+E:489[G>T:EGMGN^VYH#$H0E"-?P\WP>;V?/I)9KY/-ZJ["1(NK*LTVQ M).&REO;S^<.W%O86V>V8UHS7I?VUF!UI]:F$F8?))%9H&[3I@N#EY8*O6 L[ MD[@AN2/MD^I)D\BY;!HZK@QRUI>>#Q"9EJEK"LS!Z%V!E0)3I+RV.N<%9R MOY^51F\/)M:1EV5ZWD=87BD@<[+ 0'ET+4N'E* B8>^6S:Z_FY M)21(TFYMAMJ+YP#%R0OT4/9-M[LJ@CL?G0T?5=UL33:SD;Q*4E;3]2DD!LA+ M*2'Z7K0M4EY-R3N=W?7DQ^O[N26H&"]!# V@N3F0T)AQ5WT@E5 M:WO+CYN!6YL+:-?CP.>(V!6=0O8C 34*8Z#X&S+^VNSKCQ MO"JT\4:,=R1*Z1,%4D7^K/KY$P6J8XCS&VVMUW=6-WNV $M6DYIC)8 MZ?->ELRWLO\]&%SU&>SKEZ=>\=RU!J.\XA:T;W>]#7 W@C!1QNMQ?U.6ML$5 M+K+U9$%N@PAC]6'%/\\5-S_^<6ZV >]HZ!U*CPT#SV=BM7%*%%&&A X#,+-,G(Y9*!%JG,!R0CR),'JD M9YM/3G]["T)+"^N&E!.5=37#.TGIU3^R!;)\+'M^&CM'=G!.^X>B!A)TUL09 M3 O/8&+YUXM/Y4Y*CH$5+-?V5NB,]PPJ!JOS@2&XZ? Q/&N!&Z3* >FBQV5CC, YTFQH*EK*H(BZZ8V=\D8)* M;95[VP1J*$<2VQ+SZR [=#=0X'!JF7Z[$,^6_=.O[\8!SD"%+FO?TAX[A/XC M%]-^ .M=N1:Q0>CV](+W/U[T_AXF+U/80^_O/P@&[(F(:9YSAG/,Q1PTBG(Y M>5Q(,I<#LV=C^:BIQ <1RR=T\U%S_.N."']W%Y?_*C<'[&V>O'00! "!# H4VXX;$BD=%9:]R1YL?0F/'6\*("[NR:AI(8QE29.XP1;'*32LYFH MZZ57'R[:>!D.G!##\=ET03/>*^Q90')CD,4[7DD2>[N([(!CV=["\S)R]M"/ M#,0WZ7"7"'T6@:G@Z26CX!1Q!/$'B">S[L(#S@X&XL:UI=F,%)+D\K*:%(NB MTR<*CW1MJ*&OU37:T72(4 *GO;T5 0].4@=9#C DA Q=!D3P2WJ$TMB7,7!XXL]_2[9T787!\M)>2_K#][>BHPF MNHF1A$JH VI0*!9C3\0FY[-/DOE!02+.N448=^QJ.NKTC' X7( M#$2)-$H$) H(*P B!BNBG@#3&!CFDX%IA7>L52I&$'L/;VTVA."$^^@% ,?L M>?F+6,8P_"0)"\G"V-TTP:35DPW(%=C$\N(H8$U02\B/X[>W8&HXT!?6&1+N8314%U*:CLLA MI<(3>D8$2U),%<,]C./10(!= "$?XDH7BD3 &^#%<<]:+D^V$C,2T1\,$ X2R)ZH#B&C M/X4N&CR\",HCE-UXP*.$U2 ;!.'QCKK8W!'C@E@SC#D9(5C#RO[(U6QOC2TZ M)?B**J3%D]7_D^1DMIA-RP4,E#V6SA0W6 C!%UAN9+0'?P8$6*+K>$[/%EP3 MY4Q!VB(,L9:^+G2UKM,/9@#\>/,4B)A!+EDHY=)@#9Z;0:,;@2H2"!Y=P4!, M.FQJQJRI(,M8F'Z *+1H'DLZ7D;2I9HM>@*0,=5=$$*09S#IBJN'S8/ O!N MV]Z:LXT'J[Q*NL.X/0F>BRL0 EFFB=38C%MH5#%P":@&9@Y]-H:8,SN0*5[; M(<1$@="#:BCX^$X0E$0T'4:PK@Z=S!_XP#J^00(UYF[G$=@M=-X'Q"8*$V3C MTG@L\*YQHYO (@MU=?%EAMD7E$4:YR>^>&AC3[#3DZ/ +X$OG@KK@>\68?-> M8@(V4TP(KX"M0X@;!==GN5YG&NV\O05/P#=NKL#R%T8?;7$,#M)K$Q<5[)UB M:U;X_-S,5Z"_ GL.BSD$N%-/GSD!WZ='[A;CC2J;093@\PU9SB/0,+I03$L< MPYO[EIEF"I\D5+.+M\4PVY_TM8[F/8N1@>VM.U?<9P:'ZK\D *^:X6%"*9NZ MFTG[R.M%O!)!"^2/X0E8DLMZ8=??>T'S^^EL(9H=;,_C? 3PAPG7*+_+O< M\HOEENB;!SV^'A)\=\\!J=B08"G!RPB1]] [U:_T M:IQ>5]I?FQ_R"K&- (PU^3,[7.&7&"6]<&]^34@D@JH+/EZA M+M;JQ6Z7=R,"\4"(RV%6T&!Z@4B']:G>#<(0$1OZ'3"9<;$<(,!1U^F;-I@( M]1VWS#[W^:6ERV0;O%/^FOM]:Q0.5[QW9P/W#U]U=_W7._S2RP7\=<_'N[AG M>8BOE0)+>PWYCHA^I>"]4AM[:\AFNZUW4232>CP]6.?LR(MGV%X@<-TS8V^8 M089GR#E%U3].DQ.;#AA_'_G^N(<;NI"?*"_Q96.7_?&BFL:Z$(P$N\ WXG*P M/;LB_C FOV=LWY\SIK[T)SUXS+(#+[< MORS^B(0SU,MK_BF!XOV&;P;AC/_P0!.Y^'[C%T^#RE7S6_?N]D>[<#(> M/U68;#2_?N=?!V:SFU4Z/SM55;_Z,[]W?JE8WV\N3RN-OMOM#JJ/]1:51M9I M?WBC32]J= ^:]^51_U6C7Y:7_0[3>/KP;N0"E:N:>Q85W\=]0822>=\]-1RVV< MJJ/O]/1;KI+MML8#K?TU=W\^D>\>6Q?J7:UW 7']M'I_R"W;6/;[LUDZ; M/R_L2?.^4/AQ5 ^G5N_[]]M'SJ>5C#/>K]S<_VRU?GSQ6/+_4$L! M A0#% @ ZXEA4\[R] 8W P _@L !$ ( ! &%E M;60M,C R,3$P,C '-D4$L! A0#% @ ZXEA4VY#593]"@ ?X8 !4 M ( !9@, &%E;60M,C R,3$P,C=?;&%B+GAM;%!+ 0(4 Q0 M ( .N)85/Q@SK56@< .!7 5 " 98. !A96UD+3(P M,C$Q,#(W7W!R92YX;6Q02P$"% ,4 " #KB6%3L@,.)803 ",9P #@ M @ $C%@ 865T:&QO;E\X:RYH=&U02P4& 0 ! ! 0 &TRD end